Hledání článků
Filtry
Landray MJ, Emberson JR, Blackwell L, et al. Prediction of ESRD and death among people with CKD: the chronic renal impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 2010;56:1082–1094.
Srai SK, Chung B, Marks J, et al. Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure. Kidney Int 2010;78:660–667.
De Zeeuw Agarwal R, AmdahlM, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010 doi: 10.1016/S0140-6736(10)61032-X.
He W, Kang YS, Dai C, et al. Blockade of Wnt/ß-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 2011, doi:10.1681/ASN.2009121236.
Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 2010 Sep 1., v tisku.
Xi W, MacNab J, Lok CE, Lee TC, Maya ID, Mokrzycki MH, Moist LM. Who should be referred for a fistula? A survey of nephrologists. Nephrol Dial Transplant 2010;25:2644–2651.
Tentori F, Elder SJ, Thumma J, et al. Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrol Dial Transpl 2010;25:3050–3062.
Bernardo AP, Contesse SA, Bajo MA, Rodriques A, Del Peso G, Ossorio M, Cabrita A, Selgas R. Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis. Clin J Am Soc Nephrol 2011; doi: 10.2215/CJN06960810
Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363:2004–2014.
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int 2012;2(Suppl 4):279–336.
Turner JM, Bauer C, Abramowitz K, et al. Treatment of chronic kidney disease. Kidney Int 2012;81:351–362.
Holfthoff JH, Wang Z, Seely KA, et al. Resveratrol improves renal microcirculation, protects the tubular epitelium, and prolongs surfoval in mouse model of sepsis‑induced acute kidney injury. Kidney Int 2012,81:370–378
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; e‑pub ahead of print.
Floege J, Raggi P, Block GA, et al. Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in hemodialysis patients. Nephrol Dial Transplant 2010;25:1916–1923.
Raggi P, Chertow GM, Urena‑Torres P, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low‑dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2010;26:1327–1339.
Urena‑Torres P, Floege J, Hawley CM, et al: Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study. Nephrol Dial Transplant 2012, doi: 10.1093/ndt/gfs356
Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky L, Krishnan M, Kovesdy CP, Kalantar‑Zadeh K. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol 2012;7:332–341.